Search bioRxiv⌕ Search

Biology subjects

Moreno-Manzano, V.

Publications and source records attributed to Moreno-Manzano, V..

4 recordsLinked to original sources

Unveiling the role of miRNAs from MSC-EVs in neuroinflammation and behavioral impairments induced by chronic alcohol consumption

Extracellular vesicles derived from mesenchymal stromal cells (MSC-EVs) have emerged as a promising form of regenerative and immunomodulatory therapy; indeed, micro (mi)RNAs contained within MSC-EVs modulate target gene expression and impact disease-associated pathways. Chronic alcohol consumption results in neuroinflammation, brain damage, and impaired cognition; in this study, we asked whether the repeated intravenous administration of MSC-EVs could ameliorate neuroinflammation and behavioral impairment induced by chronic alcohol consumption in mice. MSC-EVs diminished the increased binding of a micro-positron emission tomography tracer (18F-FDG) when analyzing whole-brain 3D images and brain coronal sections of ethanol-treated mice. MSC-EV administration protected against ethanol-induced proinflammatory gene upregulation, cognitive dysfunction, and addictive-like behavior. miRNA sequencing data from MSC-EVs helped to reveal the elevated expression of EV-derived miR-483-5p and miR-140-3p in the brains of ethanol-treated mice following MSC-EV administration. In addition, MSC-EVs modulated the expression of pro-inflammatory-related miRNA target genes (e.g., Socs3, Tnf, Mtor, Atf6) in the brains of ethanol-treated mice. These results suggest that MSC-EVs could function as a neuroprotective therapy to ameliorate the neuroinflammation, cognitive dysfunction, and addictive-like behavior associated with chronic alcohol consumption.

neuroscience↗

A spinal cord injury time and severity consensus transcriptomic reference suite in rat reveals translationally-relevant biomarker genes

Spinal cord injury (SCI) is a devastating condition that leads to motor, sensory, and autonomic dysfunction. Current therapeutic options remain limited, emphasizing the need for a comprehensive understanding of the underlying SCI-associated molecular mechanisms. This study characterized distinct SCI phases and severities at the gene and functional levels, focusing on biomarker gene identification. Our approach involved a systematic review, individual transcriptomic analysis, gene meta-analysis, and functional characterization. We compiled a total of fourteen studies with 273 samples, leading to the identification of severity-specific biomarker genes for injury prognosis (e.g., Srpx2, Hoxb8, Acap1, Snai1, and Aadat) and phase-specific genes for the precise classification of the injury profile (e.g., Il6, Fosl1, Cfp, C1qc, Cp). We investigated the potential transferability of severity-associated biomarkers and identified a twelve-gene signature that predicted injury prognosis from human blood samples. We also report the development of MetaSCI-app - an interactive web application designed for researchers - that allows the exploration and visualization of all generated results (https://metasci-cbl.shinyapps.io/metaSCI). Overall, we present a transcriptomic reference and provide a comprehensive framework for assessing SCI considering severity and time perspectives. TeaserA transcriptomic meta-analysis of spinal cord injury provides a consensus reference and biomarker genes for injury phase/severity.

neuroscience↗

Emerging role of mesenchymal stem cell-derived extracellular vesicles to ameliorate hippocampal NLRP3 inflammation induced by binge-like ethanol treatment in adolescence

NOD-like receptors are innate immunity sensors that provide an early and effective response to pathogenic or injury conditions. However, abnormalities in these receptors may cause excessive inflammation. Our studies have reported that an activation of the NLRP3-inflammasome complex in ethanol-treated astrocytes and in chronic alcohol-fed mice could be associated with neuroinflammation and brain damage. Considering the therapeutic role of the molecules contained in the extracellular vesicles (EVs) derived by mesenchymal stem cells (MSC-EVs), the present study aims to evaluate whether the intravenous administration of MSC-EVs from adipose tissue, through inhibiting the NLRP3 inflammasome activation, is capable of reducing hippocampal neuroinflammation in adolescent mice treated with binge drinking. We demonstrate that MSC-EVs ameliorate the activation of the hippocampal NLRP3 inflammasome complex and other NLRs inflammasomes (e.g., NLRP1, NLRC4 and AIM2), as well as the alterations of inflammatory genes (IL-1{beta}, IL-18, iNOS, NF-{kappa}B, MCP-1 and CX3CL1) and miRNAs (miR-21a-5p, miR-146a-5p and miR-141-5p) induced by binge-like ethanol treatment in adolescent mice. Bioinformatic analysis further revealed the involvement of miR-21a-5p and miR-146a-5p with inflammatory target genes and NOD-like receptor signaling pathways. Taken together, these findings provide, for the first time, evidence of the therapeutic potential of MSC-derived EVs to restore the hippocampal neuroinflammatory response through the NLRP3 inflammasome activation induced by binge drinking in adolescence.

neuroscience↗

tappAS: A comprehensive computational framework for the analysis of the functional impact of differential splicing

Traditionally, the functional analysis of gene expression data has used pathway and network enrichment algorithms. These methods are usually gene rather than transcript centric and hence fall short to unravel functional roles associated to posttranscriptional regulatory mechanisms such as Alternative Splicing (AS) and Alternative PolyAdenylation (APA), jointly referred here as Alternative Transcript Processing (AltTP). Moreover, short-read RNA-seq has serious limitations to resolve full-length transcripts, further complicating the study of isoform expression. Recent advances in long-read sequencing open exciting opportunities for studying isoform biology and function. However, there are no established bioinformatics methods for the functional analysis of isoform-resolved transcriptomics data to fully leverage these technological advances. Here we present a novel framework for Functional Iso-Transcriptomics analysis (FIT). This framework uses a rich isoform-level annotation database of functional domains, motifs and sites -both coding and non-coding- and introduces novel analysis methods to interrogate different aspects of the functional relevance of isoform complexity. The Functional Diversity Analysis (FDA) evaluates the variability at the inclusion/exclusion of functional domains across annotated transcripts of the same gene. Parameters can be set to evaluate if AltTP partially or fully disrupts functional elements. FDA is a measure of the potential of a multiple isoform transcriptome to have a functional impact. By combining these functional labels with expression data, the Differential Analysis Module evaluates the relative contribution of transcriptional (i.e. gene level) and post-transcriptional (i.e. transcript/protein levels) regulation on the biology of the system. Measures of isoform relevance such as Minor Isoform Filtering, Isoform Switching Events and Total Isoform Usage Change contribute to restricting analysis to biologically meaningful changes. Finally, novel methods for Differential Feature Inclusion, Co-Feature Inclusion, and the combination of UTR-lengthening with Alternative Polyadenylation analyses carefully dissects the contextual regulation of functional elements resulting from differential isoforms usage. These methods are implemented in the software tappAS, a user-friendly Java application that brings FIT to the hands of non-expert bioinformaticians supporting several model and non-model species. tappAS complements statistical analyses with powerful browsing tools and highly informative gene/transcript/CDS graphs.\n\nWe applied tappAS to the analysis of two mouse Neural Precursor Cells (NPCs) and Oligodendrocyte Precursor Cells (OPCs) whose transcriptome was defined by PacBio and quantified by Illumina. Using FDA we confirmed the high potential of AltTP regulation in our system, in which 90% of multi-isoform genes presented variation in functional features at the transcript or protein level. The Differential Analysis module revealed a high interplay between transcriptional and AltTP regulation in neural development, mainly controlled by differential expression, but where AltTP acts the main driver of important neural development biological mechanisms such as vesicle trafficking, signal transduction and RNA processing. The DFI analysis revealed that, globally, AltTP increased the availability of functional features in differentiated neural cells. DFI also showed that AltTP is a mechanism for altering gene function by changing cellular localization and binding properties of proteins, via the differential inclusion of NLS, transmembrane domains or DNA binding motifs, for example. Some of these findings were experimentally validated by others and us.\n\nIn summary, we propose a novel framework for the functional analysis of transcriptomes at isoform resolution. We anticipate the tappAS tool will be an important resource for the adoption of the Functional Iso-Transcriptomics analysis by functional genomics community.

bioinformatics↗